Creative Planning’s aTyr Pharma ATYR Stock Holding History

Creative Planning’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.2K	Buy	+10,508	New	+$8.87K	﹤0.01%	4078
2025 Q3	–	Sell	-14,509	Closed	-$73.6K	–	4037
2025 Q2	$73.6K	Buy	+14,509	New	+$57.1K	﹤0.01%	3472
2018 Q2	–	Sell	-1,214	Closed	-$45K	–	2186
2018 Q1	$45K	Hold	1,214	–	–	﹤0.01%	1826
2017 Q4	$60K	Hold	1,214	–	–	﹤0.01%	1788
2017 Q3	$86K	Hold	1,214	–	–	﹤0.01%	1733
2017 Q2	$58K	Sell	1,214 -86	-7%	-$4.03K	﹤0.01%	2407
2017 Q1	$64K	Buy	1,300 +371	+40%	+$17K	﹤0.01%	2294
2016 Q4	$28K	Buy	929 +358	+63%	+$14.7K	﹤0.01%	2847
2016 Q3	$25K	Hold	571	–	–	﹤0.01%	2908
2016 Q2	$22K	Buy	+571	New	+$26.5K	﹤0.01%	2736

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's ATYR Position: Q1 2026 in Review

Creative Planning opened a new position in aTyr Pharma (ATYR) in Q1 2026: 10,508 shares worth $8.2K. The stake represents ﹤0.01% of the portfolio and ranks #4078 among its holdings. This is a return to the name: Creative Planning previously reported a position in ATYR as recently as Q2 2025.

Creative Planning first reported a position in ATYR in Q2 2016 and has held it in 10 quarters since. The position peaked at $86K in Q3 2017. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

Creative Planning held 10,508 shares of aTyr Pharma worth $8.2K as of Q1 2026.
aTyr Pharma was a new Creative Planning position in Q1 2026.
aTyr Pharma made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4078 holding.
Creative Planning first reported a position in aTyr Pharma in Q2 2016 and has held it in 10 quarters since.
Creative Planning's aTyr Pharma position peaked at $86K in Q3 2017.
111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.